Medicine
Inbrija 42 mg inhalation capsule
Inbrija 42 mg inhalation capsule is a prescription medicine containing Levodopa for inhalation use, marketed by Merz Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in a dry place between 20°C to 25°C (68°F to 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Levodopa
- Brand
- Inbrija
- Strength
- 42 mg
- Dosage form
- Inhalation capsule
- Route
- Inhalation
- Packs
- 15 blister pack, 1 blister pack, 3 blister pack and 4 more
- Marketing authorisation holder
- Merz Pharmaceuticals
- Manufacturer
- Merz Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store in a dry place between 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). INBRIJA capsules should always be stored in the blister packaging and only removed immediately before use. INBRIJA capsules should not be stored inside the INBRIJA inhaler.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N04BA01 Levodopa
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 December 2018
- Identifiers
- RxCUI 2107616, 2107621DailyMed set ID a906f8e1-6e1c-480a-8276-c01bc65dd3be, 077c0f39-a3a2-4b2b-a184-09131889dcfbNDC 10144-342, 0259-6142Application NDA209184
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 15 blister pack in 1 carton / 4 capsule in 1 blister pack | 0259-6142-60 | Merz Pharmaceuticals | 22 December 2018 |
| 1 blister pack in 1 carton / 4 capsule in 1 blister pack | 10144-342-04 | Merz Pharmaceuticals | 29 August 2019 |
| 3 blister pack in 1 carton / 4 capsule in 1 blister pack | 10144-342-12 | Merz Pharmaceuticals | 29 August 2019 |
| 4 blister pack in 1 carton / 4 capsule in 1 blister pack | 10144-342-16 | Merz Pharmaceuticals | 22 December 2018 |
| 8 blister pack in 1 carton / 4 capsule in 1 blister pack | 10144-342-32 | Merz Pharmaceuticals | 22 December 2018 |
| 15 blister pack in 1 carton / 4 capsule in 1 blister pack | 10144-342-60 | Merz Pharmaceuticals | 22 December 2018 |
| 23 blister pack in 1 carton / 4 capsule in 1 blister pack | 10144-342-92 | Merz Pharmaceuticals | 22 December 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Levodopa is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa. It is available as inhalation capsules. MedsAcross supplies Levodopa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LevodopaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Inbrija prescribing information (Merz Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Inbrija: European public assessment report (EPAR) · European Medicines Agency
Need Inbrija 42 mg inhalation capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.